Omega-3 fatty acid lipid emulsions are safe and effective in reducing endotoxemia and sepsis in acute-on-chronic liver failure: An open-label randomized controlled trial.
Anand V KulkarniLovkesh AnandAshish Kumar VyasMadhumita PremkumarAshok K ChoudhuryNirupama TrehanpatiJaya BenjaminGuresh KumarYogendra Kumar JoshiShiv Kumar SarinPublished in: Journal of gastroenterology and hepatology (2021)
Omega-3 FAs are safe and effective in reducing systemic inflammation, endotoxemia, and sepsis in patients with ACLF. These lipid emulsions could also be considered as effective sources of immunonutrition in such sick patients.
Keyphrases
- liver failure
- fatty acid
- randomized controlled trial
- hepatitis b virus
- end stage renal disease
- acute kidney injury
- intensive care unit
- ejection fraction
- septic shock
- newly diagnosed
- chronic kidney disease
- drug induced
- drinking water
- patient reported outcomes
- systematic review
- respiratory failure
- acute respiratory distress syndrome